Editorials

China’s overuse of inpatient treatment and routine preoperative testing

BMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h2918 (Published 02 June 2015) Cite this as: BMJ 2015;350:h2918
  1. Yizhi Liu, professor1,
  2. Nathan Congdon, professor123,
  3. Weirong Chen, professor1,
  4. Yuzhen Jiang, glaucoma fellow14
  1. 1 State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Centre, Sun Yat-sen University, Guangzhou, China
  2. 2Orbis International, New York, USA
  3. 3Queen’s University Belfast, Belfast, UK
  4. 4Moorfields Eye Hospital, London, UK
  1. Correspondence to: Y Liu yizhi_liu{at}aliyun.com

Moving to day case management of most ocular surgery in China is possible

China’s medical system is undergoing substantial reforms to improve access, efficiency, and quality of care.1 These changes have prompted recent suggestions in The BMJ on how efficiency could be further improved. Recommended reforms include reducing unnecessary use of intravenous fluid, currently estimated at eight bottles per capita annually,2 and restricting self medication with antibiotics for conditions such as flu, reported by a quarter of respondents in a recent survey by the China Food and Drug Administration.3

Another opportunity for improved efficiency is to stop admitting patients to hospital for non-invasive surgical care, which is common practice in China. Taking ophthalmology as an example, a tertiary public eye hospital in China typically has between 100 and 500 beds. By contrast, Moorfields Eye Hospital in London, one of the …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe